{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:41:22Z","timestamp":1792701682640,"version":"4.5.0"},"reference-count":35,"publisher":"Open Exploration Publishing","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Explor Target Antitumor Ther"],"accepted":{"date-parts":[[2026,2,5]]},"abstract":"<jats:p xml:lang=\"en\">Acquired middle-ear cholesteatoma is a histologically benign keratinizing squamous epithelial lesion that paradoxically exhibits locally destructive, recurrent, and invasive behavior, often resulting in ossicular erosion, hearing loss, labyrinthine fistula, and, rarely, intracranial complications. Surgical excision remains the primary management strategy; however, recurrence is common due to persistent microenvironmental drivers. Recent mechanistic studies\u2014including single-cell transcriptomics, spatial proteomics, and epigenetic profiling\u2014reveal a multifactorial pathogenesis orchestrated by chronic inflammation, proteolytic extracellular-matrix remodeling, osteoclast activation via RANKL and activin A, epithelial plasticity with partial epithelial-to-mesenchymal transition (EMT), and a dysbiotic, biofilm-forming microbiome. Emerging evidence further implicates oxidative stress, RNA and epigenetic modifications, miRNA dysregulation, and immune cell infiltration as central modulators of lesion chronicity and bone resorption. Collectively, these processes establish a self-sustaining pro-osteolytic microenvironment that drives bone erosion and postoperative recurrence. Cholesteatoma recapitulates several features of malignant lesions\u2014hyperproliferation, local invasion, and stromal\/immune cell recruitment\u2014yet remains fundamentally benign, lacking metastatic potential and genomic instability. Its aggression is ecological rather than genetic, highlighting the potential for microenvironment-directed, precision-based strategies. Adjunctive approaches may include local delivery of modulatory agents, targeted interference with inflammatory, proteolytic, osteoclastogenic, and microbial axes, and biomarker-guided patient stratification. Preclinical and early-phase experimental studies assessing target engagement, radiologic stabilization, and molecular surrogates of efficacy could inform safer, mechanism-driven interventions that complement surgery, reduce recurrence, and preserve hearing. Integrating molecular pathobiology with clinical strategy positions cholesteatoma as a model for benign yet locally aggressive, microenvironment-driven disease, providing a roadmap for translational therapies with direct relevance to surgical practice.<\/jats:p>","DOI":"10.37349\/etat.2026.1002359","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:21:49Z","timestamp":1771982509000},"update-policy":"https:\/\/doi.org\/10.37349\/open_exploration_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Benign, persistent, and invasive: mechanistic and translational approaches to middle\u2011ear cholesteatoma"],"prefix":"10.37349","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2249-7068","authenticated-orcid":false,"given":"Pinelopi","family":"Samara","sequence":"first","affiliation":[{"name":"Children\u2019s Oncology Hospital \u201cMarianna V. Vardinoyannis-ELPIDA\u201d, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-6921","authenticated-orcid":false,"given":"Michail","family":"Athanasopoulos","sequence":"additional","affiliation":[{"name":"Otolaryngology-Head and Neck Surgery, Athens Pediatric Center, 15125 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8439-618X","authenticated-orcid":false,"given":"Ioannis","family":"Athanasopoulos","sequence":"additional","affiliation":[{"name":"Otolaryngology-Head and Neck Surgery, Athens Pediatric Center, 15125 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21850","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"ref1","unstructured":"Kennedy KL, Singh AK. Middle Ear Cholesteatoma"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00223-023-01144-6","article-title":"Cholesteatoma Severely Impacts the Integrity and Bone Material Quality of the Incus","volume":"113","author":"Delsmann","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13102506","article-title":"Incidence Rate and Determinants of Recurrent Cholesteatoma Following Surgical Management: A Systematic Review, Subgroup, and Meta-Regression Analysis","volume":"13","author":"Massoud","year":"2025","journal-title":"Biomedicines"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jamaoto.2015.3148","article-title":"Classification of Cholesteatoma According to Growth Patterns","volume":"142","author":"Rosito","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1590\/s1808-86942011000300012","article-title":"Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases","volume":"77","author":"Aquino","year":"2011","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673404489250515074316","article-title":"Cholesteatoma: An Updated Review of Molecular Pathogenesis and Potential Therapeutic Directions","author":"Xing","year":"2025","journal-title":"Curr Med Chem"},{"key":"ref7","first-page":"628","article-title":"Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma","volume":"37","author":"Suchozebrska-Jesionek","year":"2008","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199545","article-title":"Emerging Paradigms in Cholesteatoma: From a Traditional Approach to Personalized Therapy","volume":"26","author":"Zamfir-Chiru-Anton","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.otc.2024.07.024","article-title":"Management of Cholesteatoma: Surgical Options for Disease Limited to Middle Ear\/Mastoid","volume":"58","author":"Fallon","year":"2025","journal-title":"Otolaryngol Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00690-y","article-title":"Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism","volume":"19","author":"Sch\u00fcrmann","year":"2021","journal-title":"Cell Commun Signal"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40094-3","article-title":"Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destruction","volume":"14","author":"Shimizu","year":"2023","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.21053\/ceo.2015.01662","article-title":"Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives","volume":"9","author":"Hamed","year":"2016","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59020306","article-title":"Morphopathogenesis of Adult Acquired Cholesteatoma","volume":"59","author":"Dambergs","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035538","article-title":"Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study","volume":"102","author":"Lei","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/01.mlg.0000224345.59291.da","article-title":"Expression of RANKL and OPG in middle ear cholesteatoma tissue","volume":"116","author":"Jeong","year":"2006","journal-title":"Laryngoscope"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/15384101.2024.2345481","article-title":"Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma","volume":"23","author":"Zeng","year":"2024","journal-title":"Cell Cycle"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0003489414527229","article-title":"Expression of toll-like receptors 2, 4 and nuclear factor kappa B in mucosal lesions of human otitis: pattern and relationship in a clinical immunohistochemical study","volume":"123","author":"Jesic","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.746428","article-title":"Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media","volume":"12","author":"Frank","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010199","article-title":"Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS","volume":"9","author":"Sch\u00fcrmann","year":"2020","journal-title":"Cells"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2025.2458942","article-title":"Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies","volume":"30","author":"Meng","year":"2025","journal-title":"Redox Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10162-021-00801-7","article-title":"Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma","volume":"22","author":"Yamamoto-Fukuda","year":"2021","journal-title":"J Assoc Res Otolaryngol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1188048","article-title":"Analysis of mRNA m","volume":"14","author":"Xie","year":"2023","journal-title":"Front Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512277","article-title":"Expression and Regulatory Mechanisms of MicroRNA in Cholesteatoma: A Systematic Review","volume":"24","author":"D\u017caman","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01932-5","article-title":"Identification of miRNA expression profile in middle ear cholesteatoma using small RNA-sequencing","volume":"17","author":"Xie","year":"2024","journal-title":"BMC Med Genomics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbrc.2020.02.058","article-title":"Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma","volume":"525","author":"Gong","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164826","article-title":"The Relationship between the M1\/M2 Macrophage Polarization and the Degree of Ossicular Erosion in Human Acquired Cholesteatoma: An Immunohistochemical Study","volume":"11","author":"Bassiouni","year":"2022","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13030455","article-title":"A role for mast cell-mediated antibodies in the formation of cholesteatoma and cholesteatoma-induced bone erosion","volume":"13","author":"\u00d6zdemir","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01640-6","article-title":"Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis","volume":"16","author":"Satoh","year":"2023","journal-title":"BMC Med Genomics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12105-018-0915-5","article-title":"Cholesteatoma Pearls: Practical Points and Update","volume":"12","author":"Castle","year":"2018","journal-title":"Head Neck Pathol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1021\/acsabm.2c00569","article-title":"Topical Delivery of Elastic Liposomal Vesicles for Treatment of Middle and Inner Ear Diseases","volume":"5","author":"Kashfi","year":"2022","journal-title":"ACS Appl Bio Mater"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1207141","article-title":"Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear","volume":"14","author":"Delaney","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3342\/ceo.2008.1.2.86","article-title":"Establishment and characterization of an in vitro model for cholesteatoma","volume":"1","author":"Raynov","year":"2008","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.mlg.0000251164.26405.1a","article-title":"Modeling the cholesteatoma microenvironment: coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix","volume":"117","author":"Laeeq","year":"2007","journal-title":"Laryngoscope"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/394241","article-title":"Animal models of middle ear cholesteatoma","volume":"2011","author":"Yamamoto-Fukuda","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.anl.2005.05.015","article-title":"Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma","volume":"32","author":"Takahashi","year":"2005","journal-title":"Auris Nasus Larynx"}],"container-title":["Exploration of Targeted Anti-tumor Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:21:50Z","timestamp":1771982510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.explorationpub.com\/Journals\/etat\/Article\/1002359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":35,"URL":"https:\/\/doi.org\/10.37349\/etat.2026.1002359","archive":["Portico","Portico"],"relation":{},"ISSN":["2692-3114"],"issn-type":[{"value":"2692-3114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2025-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1002359"}}